WEKO3
アイテム
Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma
http://hdl.handle.net/10091/17337
http://hdl.handle.net/10091/1733799cbc4e4-f56c-4b82-8b79-e330fdc97069
| 名前 / ファイル | ライセンス | アクション |
|---|---|---|
Platinum_anthracycline_therapy_advanced_cutaneous_squamous.pdf (177.4 kB)
|
|
| Item type | 学術雑誌論文 / Journal Article(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2014-01-21 | |||||
| タイトル | ||||||
| タイトル | Platinum and anthracycline therapy for advanced cutaneous squamous cell carcinoma | |||||
| 言語 | en | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| DOI | ||||||
| 識別子タイプ | DOI | |||||
| 関連識別子 | https://doi.org/10.1007/s10147-012-0411-y | |||||
| 関連名称 | 10.1007/s10147-012-0411-y | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Chemotherapy | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Cutaneous squamous cell carcinoma | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Skin cancer | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Platinum | |||||
| キーワード | ||||||
| 主題Scheme | Other | |||||
| 主題 | Anthracycline | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
| 資源タイプ | journal article | |||||
| 著者 |
Nakamura, Kenta
× Nakamura, Kenta× Okuyama, Ryuhei× Saida, Toshiaki× Uhara, Hisashi |
|||||
| 信州大学研究者総覧へのリンク | ||||||
| 表示名 | Okuyama, Ryuhei | |||||
| URL | http://soar-rd.shinshu-u.ac.jp/profile/ja.ZpfNHFSF.html | |||||
| 出版者 | ||||||
| 出版者 | SPRINGER JAPAN KK | |||||
| 引用 | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY. 18(3):506-509 (2013) | |||||
| 書誌情報 |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY 巻 18, 号 3, p. 506-509, 発行日 2013-06 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | Because metastatic cutaneous squamous cell carcinoma (CSCC) is rare, standard chemotherapy has not been fully established. In Japan, combination platinum and anthracycline chemotherapy has been used for elderly patients with advanced CSCC because of its low toxicity. However, the clinical benefit of this therapy has not been fully examined. We retrospectively examined the response rate of combination platinum and anthracycline chemotherapy for metastatic CSCC. Eight patients received combination chemotherapy for metastatic lesions; there were lymph node lesions in 6 patients and skin and lung lesions in one patient each. The combination regimens were as follows: cisplatin (CDDP) (60-90 mg/m(2)/day, day 1) and adriamycin (ADM) (20-40 mg/m(2)/day, day 1 or 2) was administered in 5 patients; CDDP (10-15 mg/m(2)/day, days 1-5) and epirubicin (epi-ADM) (10-15 mg/m(2)/day, days 1-5) was administered in 2 patients; and carboplatin (CBDCA) (200-400 mg/m(2)/day, day 1) and ADM (20-40 mg/m(2)/day, day 1 or 2) was administered in one patient. The responses were as follows: complete response in 2 patients (CDDP + ADM for lung metastasis, CDDP + epi-ADM for lymph node metastasis), partial response in 1 (CDDP + ADM for lymph node metastasis), stable disease in 2, and progressive disease in 3. A durable response was observed in 2 patients showing complete responses (58 and 112 months). The clinical effect of the combination of platinum and anthracycline for metastatic CSCC was limited despite the findings of two patients showing durable complete responses. | |||||
| 資源タイプ（コンテンツの種類） | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | Article | |||||
| ISSN | ||||||
| 収録物識別子タイプ | PISSN | |||||
| 収録物識別子 | 1341-9625 | |||||
| 書誌レコードID | ||||||
| 収録物識別子タイプ | NCID | |||||
| 収録物識別子 | AA11086579 | |||||
| PubMed | ||||||
| 識別子タイプ | PMID | |||||
| 関連識別子 | https://pubmed.ncbi.nlm.nih.gov/22534799 | |||||
| 関連名称 | 22534799 | |||||
| 権利 | ||||||
| 権利情報 | The original publication is available at www.springerlink.com | |||||
| 出版タイプ | ||||||
| 出版タイプ | AM | |||||
| 出版タイプResource | http://purl.org/coar/version/c_ab4af688f83e57aa | |||||
| WoS | ||||||
| 表示名 | Web of Science | |||||
| URL | http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=2&SrcAuth=ShinshuUniv&SrcApp=ShinshuUniv&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000320456500022 | |||||
